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Polybrominated diphenyl ethers (PBDEs) are 
persistent and bioaccumulative flame retar-
dants that are of concern because they are 
ubiquitous, are potentially toxic, and have 
been found at rapidly rising levels in humans 
during the past few decades [reviewed by 
Costa et al. (2008)]. PBDEs are widely used 
by industry as flame retardants in, for example, 
textiles, electrics, plastics, and furniture. Over 
time, PBDEs diffuse out of the matrix and 
bioaccumulate in the environment (Schecter 
et al. 2006). Furthermore, these chemicals 
are primarily indoor pollutants and are found 
at high levels in household dust and other 
home and workplace environmental samples 
(Schecter et al. 2005a; Stapleton et al. 2005). 
The abundance in household dust especially 
causes high exposure of toddlers and children 
(Fischer et al. 2006). PBDEs also accumu-
late in the human body; very high levels have 
recently been found in milk (Kalantzi et al. 
2004; Schecter et al. 2003, 2005b), blood 
including fetal blood (Mazdai et al. 2003; 
Morland et al. 2005; Schecter et al. 2005b; 
Sjodin et al. 2004), placenta (Doucet et al. 
2009), and adipose tissue (Johnson-Restrepo 
et al. 2005; She et al. 2002). Although lev-
els of dioxins, dibenzofurans, and polychlori-
nated biphenyls (PCBs) have been declining 
in human tissues, PBDE levels have increased 
substantially during the past two decades 
(Schecter et al. 2005b; Sjodin et al. 2004).
The high levels of PBDEs in the human 
population, especially in infants and toddlers, 
are of vast concern because these compounds 
are chemically similar to PCBs and have been 
shown to be developmentally neurotoxic 
in rodents. Various PBDE congeners cause 
behavioral alterations, such as hyperactivity, 
and disrupt performance in learning and mem-
ory tests in perinatally exposed mice and rats 
[reviewed by Costa et al. (2008)].
Despite extensive information on human 
exposure and body burden, there is no infor-
mation on possible neurodevelopmental 
adverse effects in humans from PBDE expo-
sure. Therefore, any potential risk for adverse 
nervous system effects in humans has to be 
extrapolated from animal studies (Costa et al. 
2008). To facilitate PBDE hazard assessment 
for humans, we investigated the impact of 
PBDEs on human neurodevelopment in vitro 
and studied the mechanisms underlying these 
changes. For these analyses, we used two of the 
most prominent congeners found in human 
tissues, the tetrabrominated congener BDE-47 
and the pentabrominated congener BDE-99 
[reviewed by Costa et al. (2008)]. We investi-
gated the effects of these PBDEs on the devel-
opmental neurotoxicity (DNT)–specific end 
points proliferation, migration, and differen-
tiation, as well as cell viability, in a human 
model that mimics brain development in vitro 
(Fritsche et al. 2005; Moors et al. 2007, 2009, 
2010). Furthermore, we performed competi-
tion studies with the thyroid hormone (TH) 
receptor (THR) agonist triiodothyronine (T3) 
and the THR antagonist NH-3, or {4-[4-Hy-
droxy-3-isopropyl-5-(4-nitrophenylethynyl)-
benzyl]-3,5-dimethyl}-acetic  acid,  to 
investigate the involvement of TH disruption 
in the observed effects by PBDEs.
Materials and Methods
Chemicals. BDE-47 and BDE-99 were a 
kind gift from U. Strähle from the Karlsruhe 
Institute of Technology and were diluted in 
dimethyl sulfoxide (DMSO) at stock con-
centrations of 1, 10, and 100 mM (purity of 
both PBDEs were 98.88%). 14C-BDE-47 (55 
µCi/mg, stated purity > 96%) was a kind gift 
from K. Crofton from the U.S. Environmental 
Protection Agency and was diluted in tolu-
ene at a stock concentration of 131 mM. T3 
(Sigma-Aldrich, Munich, Germany) and NH-3 
(Nguyen et al. 2002) were diluted in ethanol 
(300 mM) and DMSO (1 mM), respectively.
Cell culture. Normal human neural pro-
genitor cells (hNPCs; Lonza Verviers SPRL, 
Verviers, Belgium) generated from gestational 
week 16 were cultured as free-floating neuro-
spheres in proliferation medium [Dulbecco’s 
modified Eagle medium and Hams F12 (3:1) 
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Ba c k g r o u n d: Polybrominated diphenyl ethers (PBDEs) are persistent and bioaccumulative flame 
retardants, which are found in rising concentrations in human tissues. They are of concern for 
human health because animal studies have shown that they possess the potential to be developmen-
tally neurotoxic.
oB j e c t i v e: Because there is little knowledge of the effects of PBDEs on human brain cells, we 
investigated their toxic potential for human neural development in vitro. Moreover, we studied the 
involvement of thyroid hormone (TH) disruption in the effects caused by PBDEs.
Me t h o d s : We used the two PBDE congeners BDE-47 and BDE-99 (0.1–10 µM), which are most 
prominent in human tissues. As a model of neural development, we employed primary fetal human 
neural progenitor cells (hNPCs), which are cultured as neurospheres and mimic basic processes of 
brain development in vitro: proliferation, migration, and differentiation.
re s u l t s: PBDEs do not disturb hNPC proliferation but decrease migration distance of hNPCs. 
Moreover, they cause a reduction of differentiation into neurons and oligodendrocytes. Simultaneous 
exposure with the TH receptor (THR) agonist triiodothyronine rescues these effects on migration 
and differentiation, whereas the THR antagonist NH-3 does not exert an additive effect.
co n c l u s i o n: PBDEs disturb development of hNPCs in vitro via endocrine disruption of cellular 
TH signaling at concentrations that might be of relevance for human exposure.
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supplemented with B27 (Invitrogen GmBH, 
Karlsruhe, Germany), 20 ng/mL epidermal 
growth factor (EGF; Biosource, Karlsruhe, 
Germany), 20 ng/mL recombinant human 
fibroblast growth factor (rhFGF; R&D 
Systems, Wiesbaden-Nordenstadt, Germany), 
and penicillin and streptomycin (1:100 vol/
vol; Invitrogen) at 37°C with 7.5% CO2 
as previously described (Moors et al. 2007, 
2009). Differentiation was initiated by 
growth factor withdrawal in differentiation 
medium [Dulbecco’s modified Eagle medium 
and Hams F12 (3:1) supplemented with N2 
(Invitrogen)] and plating onto a poly-d-lysine/
laminin matrix.
Chemical exposure. For viability, migra-
tion, and differentiation analyses, neuro-
spheres were preincubated for 1 week with 
PBDEs (0.1, 1, or 10 µM) in proliferation 
medium; afterward, differentiation was initi-
ated and spheres differentiated with the same 
concentrations of PBDEs in differentiation 
medium for 48 hr (migration measurements) 
or 7 days (differentiation analyses). This treat-
ment scheme is supposed to imitate exposure 
of fetal cells during expansion and differentia-
tion in vivo. For proliferation analyses, neuro-
spheres were treated for 2 weeks with PBDEs 
(0.1, 1, or 10 µM) in proliferation medium. 
For cotreatment with T3 or NH-3, spheres 
were incubated for 48 hr (migration) or 7 days 
(differentiation) with the indicated concentra-
tions after differentiation was initiated.
Viability assay. Cell viability was measured 
using the alamarBlue assay (CellTiter-Blue 
assay, Promega, Madison, WI, USA), which 
measures mitochondrial reductase activity, and 
the CytoTox-ONE assay (Promega), which 
determines lactate dehydrogenase release, 
according to the manufacturer’s description. In 
addition, to determine whether PBDEs cause 
cell death in differentiating cells in the migra-
tion area, cells were incubated for 5 min with 
0.1% trypan blue (Sigma-Aldrich). Afterward, 
dead cells were counted under a light-field 
microscope (Olympus, Hamburg, Germany).
Proliferation analyses. For proliferation 
analyses, spheres were cultured in prolifer-
ation medium with or without 20 ng/mL 
EGF/rhFGF as previously described (Moors 
et al. 2009). After 0 and 14 days, sphere 
size was determined by software analyses 
(MetaMorph, version 7.1; Universal Imaging 
Corp., West Chester, PA, USA).
Migration assay. For analyses of hNPC 
migration, the distance from the edge of the 
sphere to the farthest migrated cells was meas-
ured 48 hr after initiation of differentiation 
at four defined positions per sphere (Moors 
et al. 2007).
Immunocytochemistry. After differenti-
ating for 7 days, the cells were fixed in 2% 
paraformaldehyde for 30 min and stored in 
phosphate-buffered saline (PBS) at 4°C until 
immunostaining was performed. For anti-
bodies against intracellular epitopes, the fixed 
slides were washed twice for 5 min each in 
PBS containing 0.1% Triton X-100 (PBS-T). 
After that, slides were incubated with primary 
antibodies for 30 min at 37°C in PBS-T con-
taining 10% goat serum. After three additional 
washes with PBS, the cells were incubated 
for 30 min with appropriate fluorochrome-
labeled secondary antibodies in PBS contain-
ing 0.1 µg/mL Hoechst 33258 to label cell 
nuclei, followed by three washes with PBS for 
10 min each. After brief drying, slides were 
mounted with Vectashield mounting medium 
(Linaris, Wertheim, Germany). For antibod-
ies against cell-surface epitopes, the same 
protocol was used with the exception that 
PBS-T was replaced by PBS in all steps. The 
primary antibodies were mouse monoclonal 
IgG anti-β(III)tubulin (1:100; Sigma-Aldrich) 
and mouse monoclonal IgM anti-O4 (1:50; 
Millipore, Billerica, MA, USA). The appropri-
ate secondary antibodies were coupled with 
Alexa Fluor 488 or rhodamine red (1:100; 
Jackson ImmunoResearch, Dianova GmbH, 
Hamburg, Germany). For analyses, slides 
were examined with a fluorescence microscope 
(Olympus), and photomicrographs were taken 
at the edge of the sphere with a ColorViewXS 
digital camera (Olympus). Stained cells were 
counted manually in relation to the total num-
ber of nuclei in the field.
RNA preparation and reverse-tran-
scriptase polymerase chain reaction. Total 
RNA was prepared from five differentiated 
neurospheres either untreated or treated 
with 10 µM PBDE using the Absolutely 
RNA Microprep Kit (Stratagene, La Jolla, 
CA, USA). Real-time reverse-transcriptase 
polymerase chain reaction (RT-PCR) was 
performed as previously described (Fritsche 
et al. 2007). Primer sequences for nestin are 
CAGCTGGCGCACCTCAAGATG (for-
ward) and AGGGAAGTTGGGCTCA 
GGACT (reverse). Primer sequences for β-actin 
are CCCCAGGCACCAGGGCG  TGAT (for-
ward) and GGTCATCTTCTCGCGGTT 
GGCCTTG  GGGT (reverse).
Calcium imaging. We treated neuro-
spheres for 1 week with 10 µM BDE-47 or 
BDE-99. Subsequently, differentiation was 
induced under ongoing PBDE exposure. After 
24 hr, ratiometric calcium imaging was per-
formed using a wide-field epifluorescence sys-
tem (TILL Photonics, Martinsried, Germany) 
attached to an upright microscope (Axioskop; 
Zeiss, Oberkochen, Germany) with a 40× 
water-immersion objective (0.8 numer-
ical aperture; Olympus Europe, Hamburg, 
Germany). Excitation was generated by a 
monochromator; emission was detected by 
a CCD camera (imago super-VGA; TILL). 
Cells were passively loaded by addition of the 
calcium indicator dye fura-2 acetoxymethyl 
ester (15 µM; Teflabs, Invitrogen) for 90 min. 
Fura-2 fluorescence was alternately excited 
at the isosbestic point (357 nm) and at the 
calcium-sensitive wavelength (380 nm), and 
the ratio of fluorescence emission (F357/F380) 
in regions of interest positioned around cell 
somata was calculated. Adenosine triphosphate 
(ATP) and acetylcholine (ACh) were puff-
applied using a Picospritzer II (General Valve/
Parker Hanifin, Flein/Heilbronn, Germany) 
coupled to standard micropipettes with a 
tip diameter of around 1.5 µm (Hilgenberg, 
Waldkappel, Germany) placed at a distance of 
approximately 10–20 µm above the cell layer. 
Data analysis was performed using TILLVision 
and IgorPro software (Wavemetrics, Lake 
Oswego, OR, USA). To determine effects 
on [Ca2+]i, we used the normalized F357/F380 
ratio for puff application. Any change in the 
normalized ratios to ≥ 1.2 was considered an 
increase and was used for further data analysis.
14C-BDE-47 accumulation. After mito-
gen withdrawal neurospheres were allowed to 
attach to culture dish for 4 hr; afterward, cells 
were exposed to 1 µM 14C-BDE-47. The cells 
were incubated for 7 days at 37°C, and half 
of the medium was changed every 2 days. At 
the end of the incubation period, the medium 
was removed, and cells were washed once with 
500 µL PBS. Cells were lysed in 100 µL lysis 
buffer (Stratagene). 14C-BDE-47 concentra-
tions were determined by liquid scintillation 
counting in residual medium and cell lysates in 
Roti-Szint (Carl Roth, Karlsruhe, Germany). 
Intracellular 14C-BDE-47 concentrations were 
calculated after background subtraction (same 
treatment without spheres) by a standard con-
centration curve and normalized to sphere 
volumes. Percent nonspecific binding to the 
culture dish was determined by subtracting 
intracellular and medium 14C-BDE-47 from 
total 14C-BDE-47 added to the cultures.
Statistics. For multifactor analyses analysis 
of variance in combination with the Bonferroni 
post hoc test was used. Student’s t-test was used 
for two group comparison. The significance 
value was set at p ≤ 0.05.
Results
Effects of PBDEs on hNPC viability. To deter-
mine viability of cells, we preincubated spheres 
for 7 days with different concentrations of 
BDE-47 or BDE-99 under proliferating con-
ditions followed by further differentiation in 
presence of PBDEs for 7 days or for 14 days 
as proliferating spheres. Neither mitochon-
drial activity nor release of lactate dehydro-
genase changed significantly compared with 
the DMSO controls. Additionally, visual 
inspection of migration areas after staining 
with 0.1% trypan blue indicated that in all 
samples the number of dead or damaged cells 
was < 1% (data not shown). Thus, BDE-47 
or BDE-99 did not cause cytotoxicity of Schreiber et al.
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hNPC [see Supplemental Material, Figure 1 
(doi:10.1289/ehp.0901435)].
Effects of PBDEs on hNPC proliferation. 
For assessment of hNPC proliferation, we cul-
tured neurospheres with and without PBDEs 
(0.1–1 µM) for 2 weeks. We determined 
increases in cell number by measuring sphere 
diameter (Moors et al. 2009). In contrast to 
the negative control without mitogens, PBDEs 
did not impair sphere growth over time [see 
Supplemental Material, Figure 2 (doi:10.1289/
ehp.0901435)].
Effects of PBDEs on hNPC migration. To 
measure migration, we determined the dis-
tance between the sphere edge and the farthest 
migrated cells 48 hr after plating. The solvent 
controls migrated 942.1 ± 42.9 µm within 
48 hr, whereas BDE-47–treated hNPCs 
migrated 838.9 ± 11.6 µm (89.0 ± 1.2% of 
control; 0.1 µM), 755.3 ± 20.7 µm (80.2 ± 
2.2% of control; 1 µM), and 660.7 ± 21.4 µm 
(70.1 ± 2.3% of control; 10 µM) and BDE-99 
exposed cells migrated 781.9 ± 14.8 µm (83.0 
± 1.6% of control; 0.1 µM), 674.5 ± 24.4 µm 
(71.6 ± 2.6% of control; 1 µM), and 609.6 
± 33.6 µm (64.7 ± 3.6% of control; 10 µM). 
These data show that PBDEs reduce hNPC 
migration in a concentration-dependent man-
ner (Figure 1).
Effects of PBDEs on hNPC differentia-
tion. To investigate the influence of PBDEs 
on differentiation of hNPCs, we preincubated 
spheres with PBDEs for 7 days under pro-
liferating conditions. After 7 additional days 
of differentiation under PBDE exposure, we 
performed immunocytochemical staining for 
β(III)tubulin (neurons) and O4 (oligoden-
drocytes; Figure 2). The number of control 
and PBDE-exposed nuclei in the differentia-
tion zones, visualized with Hoechst, did not 
differ [see Supplemental Material, Figure 3 
(doi:10.1289/ehp.0901435)]. Manual count-
ing of immunopositive cells under blinded 
conditions revealed that 26.6 ± 3.2% of the 
control cells were positive for β(III)tubulin, 
whereas PBDE exposure reduced immunopo-
sitive cells to 21.6 ± 1.8% (0.1 µM), 16.8 ± 
2.1% (1 µM), and 13.3 ± 3.0% (10 µM) for 
BDE-47 and to 16.3 ± 1.5% (0.1 µM), 13.4 
± 0.5% (1 µM), and 8.3 ± 2.0% (10 µM) 
for BDE-99. The effects of PBDE exposure 
on oligodendrogenesis were stronger than on 
neurogenesis. Although 5.7 ± 0.8% of all dif-
ferentiated cells were immunoreactive for O4 
after 7 days of differentiation in the control 
cultures, in the BDE-47–exposed groups only 
4.5 ± 0.5% (0.1 µM), 3.9 ± 0.6% (1 µM), 
and 2.8 ± 0.6% (10 µM) stained O4 posi-
tive, and in the BDE-99–treated cells 4.5 ± 
0.6% (0.1 µM), 2.7 ± 0.6% (1 µM), and 0.4 
± 0.4% (10 µM). Thus, PBDEs inhibit neural 
differentiation of hNPCs in a concentration-
dependent manner.
To determine whether PBDEs lead to cell 
type–specific inhibition of migration, causing 
cells to remain within the sphere, or whether 
PBDEs lead to an actual delay in differen-
tiation, we performed real-time RT-PCR 
analyses of the entire spheres with nestin, a 
marker of undifferentiated progenitor cells. 
Control spheres displayed only weak expres-
sion of nestin after 7 days of differentiation. 
In contrast, BDE-47 and BDE-99 increased 
nestin expression 4- and 5-fold, showing 
that PBDEs delay differentiation of hNPCs 
(Figure 3B).
PBDEs interfere with THR signal trans-
duction. To study involvement of endocrine 
disruption in the observed PBDE effects, 
we employed the THR agonist T3 and the 
antagonist NH-3. After initiating differentia-
tion, we exposed the spheres to 10 µM BDE-
47 or BDE-99 with or without 3 nM T3 
or 1 µM NH-3. Stimulation with T3 alone 
increased migration distance significantly to 
1181.6 ± 7.4 µm (121.1 ± 0.6% of control) 
compared with 975.6 ± 7.4 µm in the con-
trols (Figure 3A). In contrast, NH-3 inhib-
ited migration of hNPCs to 735.2 ± 7.2 µm, 
(78.2 ± 1.8% of controls). Coadministration 
of BDE-47 or BDE-99 and T3 rescued the 
inhibitory effects of PBDEs completely, the 
cells migrated over a distance of 1107.4 ± 
8.4 µm (113.5 ± 1.2% of control; BDE-47) 
and 1109.2 ± 18.6 µm (113.8 ± 2.6% of con-
trol; BDE-99). In contrast, cotreatment of 
PBDEs with NH-3 did not have an additive 
effect, indicating that these substances inhibit 
migration through an identical mechanism.
To address the question of whether endo-
crine disruption of the TH system is also 
responsible for PBDE-induced changes in 
differentiation, we analyzed nestin expression 
7 days after cotreatment with PBDEs and 
T3 or NH-3. T3 rescued the PBDE-induced 
cellular increase in nestin expression, whereas 
NH-3 showed no additive effects in combina-
tion with PBDEs (Figure 3B). These results 
support the notion that PBDEs delay neu-
ral differentiation by interfering with cellular 
THR signaling.
PBDEs do not influence calcium signal-
ing. We treated neurospheres for 1 week with 
10 µM BDE-47 or -99. Subsequently, we 
induced differentiation under ongoing PBDE 
exposure. After 24 hr, we stimulated neuro-
spheres with 1 mM ATP or 500 µM ACh 
to induce calcium signaling. ATP caused a 
[Ca2+]i increase in 94.7 ± 4.1% of all cells 
with a maximal amplitude of 1.5 ± 0.1, 
whereas ACh caused a [Ca2+]i elevation in 
29.2 ± 3.6% of all cells with an amplitude of 
1.32 ± 0.0. However, BDE-47 and BDE-99 
did not change number of responding cells or 
amplitude of response (Figure 4).
PBDEs accumulate in hNPCs. Exposure 
of hNPCs to 1 µM 14C-BDE-47 for 7 days 
resulted in a cellular concentration of 61.16 
± 6.34 µM, which equals an accumula-
tion factor of 60. Only 2% of 14C-BDE-47 
remained in the media, indicating that 91% 
of 14C-BDE-47 was bound to the culture 
dish [see Supplemental Material, Figure 4 
(doi:10.1289/ehp.0901435)].
Figure 1. PBDEs inhibit migration of neural progenitor cells: phase-contrast images (A) and quantification 
(B) of cell migration. Migration distance was measured at four defined spots from the edge of the sphere 
to the farthest migrated cell after 48 hr. All data are mean ± SE of three independent experiments (five 
spheres/experiment). Bars, 200 µm.
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Discussion
Human exposure to brominated flame retar-
dants is of concern because PBDEs impair 
neurodevelopment in animals, rising con-
centrations of these compounds are found in 
human tissues, and nothing is known about 
their developmentally neurotoxic effects 
in humans (Costa et al. 2008). Moreover, 
the mechanisms by which PBDEs interfere 
with brain development are not known. To 
shed light onto the effects caused by PBDE 
exposure in human developing brain cells, 
we studied their effects on the development 
of hNPCs in vitro. These cells are primary 
human fetal neuroprogenitors and grow as 
three-dimensional, complex cellular systems, 
called neurospheres, in culture. Recently, we 
have established several end points for DNT 
testing in such neurospheres—proliferation, 
migration, differentiation, and apoptosis—by 
employing end-point–specific controls 
(Moors et al. 2007, 2009). We showed that 
this neurosphere system is able to reveal exog-
enously induced disturbances in these basic 
processes of brain development. In the present 
study, we applied this novel testing method 
to unravel the DNT potential of PBDEs for 
such developing human cells.
PBDEs (0.1–10 µM) are not cytotoxic for 
proliferating or differentiating hNPCs over a 
period of 2 weeks, as we demonstrated by dif-
ferent, independent methods [see Supplemental 
Material, Figures 1 and 2 (doi:10.1289/
ehp.0901435)]. In contrast to our findings, 
the technical PBDE mixture DE-71 (> 20 µM) 
caused cell death in rat cerebellar granule cells 
(Reistad et al. 2006), and BDE-99 (> 25 µM) 
induced cytotoxicity in human astrocytoma 
cells (Madia et al. 2004). BDE-47 was reported 
to cause cell death in hippocampal neurons 
(41.2 µM), human neuroblastoma cells 
(> 5 µM), and human fetal liver hematopoietic 
cells (> 50 µM) (He et al. 2008a, 2008b; Shao 
et al. 2008). Moreover, the higher brominated 
congener BDE-209 (> 10 µM) was toxic to 
human HepG2 hepatoma cells (Hu et al. 
2007). The cause of cytotoxicity in all these 
different cell models was induction of apopto-
sis. Giordano et al. (2008) demonstrated that 
DE-71 exposure induces oxidative stress. This 
production of reactive oxygen species is respon-
sible for DE-71–induced apoptosis of rat cere-
bellar granule neurons (CGN), as indicated by 
intracellular glutathione (GSH) content, which 
is a most important determinant of CGN sus-
ceptibility to DE-71 neurotoxicity. Moreover, 
transgenic rat neuron/astrocyte cocultures with 
proficient versus deficient GSH synthesis sup-
port these findings: Astrocytes rich in GSH 
protected neurons against DE-71–induced 
neurotoxicity, whereas astrocytes poor in 
GSH content did not (Giordano et al. 2009). 
Protection of neurons against PBDE-induced 
cytotoxicity by the presence of astrocytes is 
thus the probable reason for differentiated 
hNPC insensitivity toward PBDE-dependent 
Figure 2. PBDEs inhibit differentiation of hNPCs. (A) Representative photomicrographs of hNPCs after 7 days of differentiation. Cells were stained with anti-
bodies against β(III)tubulin [β(III)Tub+] for neurons and O4+ for oligodendrocytes. Cell nuclei were counterstained with Hoechst. Bars, 50 µm. (B) Quantification of 
immuno  staining after PBDE treatment. All data are mean ± SE of three independent experiments (five spheres/experiment). 
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cell death, whereas proliferating precursors are 
known to possess better defense mechanisms 
than do postmitotic neural cells (Madhavan 
et al. 2006). Moreover, such human coculture 
systems, such as differentiated neurospheres, 
where the three major cell types of the brain 
are present in “physiological” ratios, seem to be 
superior in vitro methods for assessing hazards 
of chemicals to humans compared with simple 
monolayer cell lines.
Neurosphere proliferation assessed by 
monitoring of sphere diameter (Moors et al. 
2009) was also not affected by presence of 
BDE-47 or -99 [see Supplemental Material, 
Figure 2 (doi:10.1289/ehp.0901435)]. This is 
in agreement with results from a T-Screen assay 
(Gutleb et al. 2005), a functional assay based on 
T3-dependent cell proliferation of the rat GH3 
pituitary tumor cell line, where also no effects 
of these two congeners on proliferation were 
observed (Hamers et al. 2006). In contrast, 
one of the hydroxylated BDE-47 metabolites, 
2-OH-BDE-47 (5–10 µM), inhibited prolif-
eration of the H295R adrenocortical carcinoma 
cell line (Song et al. 2009). However, this con-
centration of reactive metabolite causing an 
antiproliferative effect in these cells is high, and 
the researchers did not investigate effects of the 
parent compound. Inhibition of proliferation 
by BDE-47 was also seen in 5L rat hepatoma 
cells (Wahl et al. 2008). However, the research-
ers demonstrated that arylhydrocarbon receptor 
(AhR) activation by the BDE-47 contaminant 
1,2,3,7,8-pentabromodibenzofuran was respon-
sible for the effects on proliferation, rather than 
BDE-47 itself. Highly purified BDE-47 does 
not stimulate the AhR (Peters et al. 2004). This 
supports our data because PBDEs used in the 
present study are contaminant-free. Increased 
proliferation was observed in DE-71–treated 
MCF-7 breast cancer cells. This stimulation was 
estrogen receptor dependent, so DE-71 acts as 
an endocrine disruptor in this estrogen recep-
tor–positive cell line (Mercado-Feliciano and 
Bigsby 2008). Hence, interaction of PBDEs 
with cell proliferation seems to be congener and 
cell type specific. So far, all data available on this 
topic have been obtained in tumor cells. This is, 
to our knowledge, the first report employing 
normal human cells or human stem/  progenitor 
cells for determining effects of PBDEs on 
cell proliferation.
In contrast to proliferation, both investi-
gated PBDE congeners inhibit migration and 
differentiation of hNPCs significantly in a 
concentration-dependent manner (Figures 1 
and 2). Consequences of PBDE exposure for 
cell migration have not been investigated so 
far in any cell type in vitro or in vivo, so this 
is the first report showing that these chemicals 
have the ability to interfere with human pro-
genitor cell motility. However, a recent pro-
teomics study by Alm et al. (2008) suggests 
that PBDE exposure might cause disturbances 
in cell motility also in vivo. In that study, a 
single dose of BDE-99 given on mouse post-
natal day 10 caused changes in brain pro-
tein expression after 24 hr, and one-third of 
those proteins were related to the cytoskel-
eton, including actin. The importance of the 
actin cytoskeleton for neuronal migration has 
been reviewed extensively (Luo 2002), leaving 
room for the speculation that PBDEs might 
interfere with migration through alteration of 
cytoskeleton-related protein expression.
Similar to PBDE effects on neural migra-
tion, to our knowledge, consequences of 
PBDE exposure for neural differentiation have 
not been studied so far. Therefore, this is the 
first report showing that this group of flame 
retardants can directly interfere with birth of 
neurons and oligodendrocytes in this human 
in vitro model. Interference of BDE-47 with 
neuronal differentiation was also suggested 
in the fathead minnow because this congener 
reduced basic transcription element–binding 
protein (BTEB) expression in their brains 
(Lema et al. 2008). BTEB is known to be 
involved in neural differentiation in rodents 
(Denver et al. 1999). Moreover, BDE-99 
altered protein expression of growth-associated 
protein-43 and brain-derived neurotrophic 
Figure 3. PBDEs disrupt cellular TH signaling. (A) hNPC migrated for 48 hr in the presence of the indicated 
substances, and migration distance was quantified. (B) hNPCs differentiated for 7 days in the presence of 
the indicated substances. Proliferating neurospheres (Prolif nsph) were used as positive control. Real-time 
PCR analyses for nestin were quantified with a product-specific copy number standard and normalized for 
β-actin expression. All data (% DMSO control) are shown as mean ± SE of three independent experiments 
(five spheres/experiment). 
*p ≤ 0.05 versus control; #p ≤ 0.05 versus respective PBDE treatment.
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factor in developing rodent brains (Alm et al. 
2008). Both proteins are closely related to 
neural development and plasticity [reviewed 
by Strittmatter et al. (1992) and Binder and 
Scharfman (2004)]. Whether PBDEs dis-
turb brain development by interfering with 
migration and differentiation not only in vitro 
but also in vivo needs to be investigated by 
appropriate animal experiments. However, 
because our study was performed in normal 
cells of human origin, possible species differ-
ences should first be addressed by migration 
and differentiation analyses in rodent neuro-
spheres. Moreover, the developmental stage of 
cells needs to be considered for rodent in vitro 
and in vivo analyses: hNPC generated from 
gestational week 16 correspond approximately 
to embryonic day 16 to postnatal day 3 of 
mouse development.
During normal development, neural 
migration and maturation of neural and glial 
cells are guided by TH (Alvarez-Dolado et al. 
1999; Wong and Leung 2001). Therefore, 
hypothyroidism during development causes 
a large number of neuroanatomical and 
behavioral effects (Haddow et al. 1999; 
Schalock et al. 1977; Zoeller and Crofton 
2005). Because of similar neurobehavioral 
alterations observed after PBDE exposure in 
rodents, endocrine disruption of the TH sys-
tem by PBDEs has been studied intensively. 
Hypothyroidism of dams and/or offspring 
was found in a variety of different studies 
after pre- or postnatal exposure [reviewed by 
Costa et al. (2008)]. This reduction in serum 
thyroxine (T4) or T3 levels is thought to be 
caused by induction of the phase II enzyme 
UDP-glucuronosyl transferase, causing accel-
erated TH metabolism (Zhou et al. 2002), 
and by preventing TH from binding to its 
plasma transport protein transthyretin (Meerts 
et al. 2000). However, behavioral toxicity of 
BDE-47 without alterations in serum T4 and 
T3 levels was also observed, suggesting that 
PBDEs cause toxicity by a mechanism beyond 
changes in body TH homeostasis (Gee and 
Moser 2008; Gee et al. 2008). These stud-
ies might be explained by the data generated 
in our experiments because the two PBDE 
congeners BDE-47 and -99 directly disturb 
migration and delay differentiation of hNPCs 
in vitro by endocrine disruption of cellular 
TH signaling. We confirmed this by two 
observations: a) PBDE actions are completely 
antagonized by cotreatment of neurospheres 
with T3 and b) simultaneous administration 
of PBDE and the THR antagonist NH-3 
did not cause an additive effect. Although 
NH-3 binds to THRα as well as THRβ, it 
has a higher affinity to THRβ (Nguyen et al. 
2002). Because inhibition of THRα leads to 
decreased proliferation of avian neurogenic 
precursors (Lezoualćh et al. 1995; but PBDEs 
do not interfere with hNPC proliferation), 
and the induction of THRβ induces neural 
differentiation (Jones et al. 2003; Lebel et al. 
1994; and PBDEs disturb neural differen-
tiation of hNPCs), it is likely that PBDEs 
interfere with THRβ signaling of hNPCs. 
However, reporter gene analyses in THRα 
and β overexpressing Chinese hamster ovary 
cells revealed that neither PBDE congener 
acted as agonist or antagonist of THRα or 
THRβ. One possible reason for discrepancies 
between our study and results in the overex-
pression system might be that PBDEs act via 
disturbance of recruitment of THR cofac-
tors. In primary cells, receptors, cofactors, 
and responsive elements are present at a fine-
tuned equilibrium, which is not the case in 
transfected cells, which overexpress only cer-
tain elements of the cellular machinery. That 
nuclear hormone receptor cofactors might be 
crucial in endocrine disruption by polyhaloge-
nated aromatic compounds is discussed in our 
previous work (Fritsche et al. 2005), in which 
we found that the noncoplanar PCB-118 
induced oligodendrocyte differentiation in 
hNPCs. That in vitro work represented the 
finding in vivo that Aroclor treatment led to 
an increased expression of TH-dependent 
genes such as RC3/neurogranin and myelin 
basic protein in fetal rat brains (Zoeller et al. 
2000). To our knowledge, an equivalent 
rodent study has not yet been performed with 
PBDEs. Only in the fathead minnow, TH 
disruption on the basis of THR-dependent 
gene expression was observed after BDE-47 
exposure (Lema et al. 2008). Thus, this is the 
first work showing that PBDEs can directly 
interfere with cellular TH signaling in human 
neural cells.
Besides endocrine disruption, we also 
investigated whether PBDEs disturb calcium 
homeostasis. Calcium signaling is a key player 
in developmental processes (Ciccolini et al. 
2003; Greer and Greenberg 2008), and BDE-
47 disturbs calcium homeostasis in rat PC12 
pheochromocytoma cells after 20 min of 
exposure (Dingemans et al. 2008). BDE-47 
exerts similar short-term effects on hNPCs 
(Gassmann K, Krause G, Dingemans M, 
Schreiber T, Abel J, Bergman A, et al., 
unpublished observations). To test whether 
long-term exposure (1 week) to PBDEs also 
influences calcium signaling and thus contrib-
utes to the developmentally neurotoxic effects 
of PBDEs in hNPC, we measured calcium 
signaling in PBDE treated hNPCs stimu-
lated with ATP or ACh. Neither BDE-47 nor 
BDE-99 influenced the response of the cells 
toward these stimuli, indicating that they do 
not alter expression of proteins involved in 
Ca2+ flux. Recently, Viberg (2009) showed 
that BDE-203 and BDE-206 increase 
Ca2+/calmodulin-dependent protein kinase 
(CaMKII) expression in mouse hippocampus. 
Whether PBDEs interfere with downstream 
targets of calcium signaling in hNPCs, such 
as CaMKII or calcineurin, has to be further 
elucidated.
In summary, BDE-47 and BDE-99 dis-
turb neural migration and differentiation in 
a human in vitro model for brain develop-
ment by disruption of cellular TH signaling. 
The question is now how the lowest observed 
effect levels from this study relate to actual 
human PBDE exposure. Therefore, we meas-
ured intracellular PBDE concentrations by 
employing 14C-BDE-47. Because medium 
concentration-dependent intracellular PBDE 
accumulation in vitro follows a linear kinetic 
(Mundy et al. 2004) and neurosphere mate-
rial is limited, we measured only 1 µM 14C-
BDE-47 medium concentration. After 7 days 
of differentiation, PBDE accumulation is 
approximately 60-fold. These data support 
other in vitro data where PBDEs accumulate 
up to 100-fold in neuronal cells (Mundy et al. 
2004). It also reflects PBDE accumulation in 
postnatal day 10 and 19 mouse brains after 
7 days in vivo (20- to 140-fold) that we cal-
culated from a study of Viberg et al. (2003). 
PBDE exposure of human infants through 
breast milk is up to 4,000 ng/kg/day (Jones-
Otazo et al. 2005). Assuming an average 
molecular weight of 500 g/mol for PBDEs, 
this equals an exposure of 8 nM. Taking into 
account that there is a 60-fold increase in tis-
sue concentration of PBDEs in our human 
in vitro system and up to a 140-fold increase 
in brain tissue in mice after oral exposure 
in vivo (Viberg et al. 2003), infant exposure 
could result in a brain concentration of 0.5–
1.1 µM. Considering that 0.1 µM BDE-99 
(~ 6 µM tissue concentration) decreases neu-
ronal differentiation by approximately 40% 
(Figure 2), current PBDE exposure levels are 
likely to be of concern for human health.
Assessing subtle changes in human IQ 
or behavior in epidemiologic studies is not 
trivial and needs large numbers of study sub-
jects. Such investigations are needed to reveal 
whether PBDEs as a hazard identified in this 
study actually pose a risk for human brain 
development in vivo.
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